Literature DB >> 6337794

Effects of intra- and extrahepatic portal systemic shunts on insulin metabolism.

K Ohnishi, A Mishima, M Takashi, S Tsuchiya, S Iida, S Iwama, N Goto, K Kono, Y Nakajima, N Suzuki, H Musha, K Okuda.   

Abstract

To study the effects of intra- and extrahepatic portal-systemic shunts on insulin degradation, 11 patients with liver cirrhosis and 7 noncirrhotic patients with liver disease were studied with percutaneous transhepatic catheterization. Insulin levels in portal and peripheral blood were measured simultaneously for 1-2 hr after intravenous administration of glucose. The degrees of intra- and extrahepatic portal-systemic shunting were measured with this technique using 131I-macroaggregated albumin and 99mTc-macroaggregated albumin. The amount of insulin secreted and insulin degraded were assessed from the areas under blood concentration curves for portal and peripheral blood. Insulin degradation was significantly reduced in cirrhotics compared to noncirrhotics with liver disease, although there was no difference in the amount of insulin secreted between these two groups. It was also correlated significantly with the degree of intrahepatic shunting but not with the degree of extrahepatic shunting. These results suggest that intrahepatic shunting plays an important role in the reduction of insulin degradation in cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337794     DOI: 10.1007/bf01295114

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Letter: Intrahepatic portasystemic shunting in cirrhotic patients.

Authors:  G Gross; C V Perrier
Journal:  N Engl J Med       Date:  1975-11-13       Impact factor: 91.245

2.  Percutaneous transhepatic catheterization of the portal vein for the study of portal hemodynamics and shunts. A preliminary report.

Authors:  K Okuda; K Suzuki; H Musha; N Arimuzu
Journal:  Gastroenterology       Date:  1977-08       Impact factor: 22.682

3.  Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis.

Authors:  A V Greco; F Crucitti; G Ghirlanda; R Manna; L Altomonte; A G Rebuzzi; A Bertoli
Journal:  Diabetologia       Date:  1979-07       Impact factor: 10.122

4.  Critical variables in the radioimmunological technique for measuring immunoreactive insulin with use of immunosorbents.

Authors:  C A Velasco; W Oppermann; R A Camerini-Davalos
Journal:  Clin Chem       Date:  1973-02       Impact factor: 8.327

5.  A controlled study of the prophylactic portacaval shunt. A final report.

Authors:  R H Resnick; T C Chalmers; A M Ishihara; A J Garceau; A D Callow; E M Schimmel; E T O'Hara
Journal:  Ann Intern Med       Date:  1969-04       Impact factor: 25.391

6.  Detection of hepatic shunts by the use of 131-I-macroaggregated albumin.

Authors:  H Ueda; K Kitani; H Kameda; H Yamada; M Iio
Journal:  Gastroenterology       Date:  1967-03       Impact factor: 22.682

7.  Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs.

Authors:  T E Starzl; K Watanabe; K A Porter; C W Putnam
Journal:  Lancet       Date:  1976-04-17       Impact factor: 79.321

8.  Effect of spontaneous portal-systemic shunting on plasma insulin and amino acid concentrations.

Authors:  Y Iwasaki; H Sato; A Ohkubo; T Sanjo; S Futagawa; M Sugiura; S Tsuji
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

9.  Degradation and secretion of insulin in hepatic cirrhosis.

Authors:  Y Iwasaki; A Ohkubo; H Kajinuma; Y Akanuma; K Kosaka
Journal:  J Clin Endocrinol Metab       Date:  1978-10       Impact factor: 5.958

10.  Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?

Authors:  D G Johnson; K G Alberti; O K Faber; C Binder
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

View more
  1 in total

1.  Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions.

Authors:  A V Greco; G Mingrone; A Mari; E Capristo; M Manco; G Gasbarrini
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.